BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heinrich MA, Mostafa AMRH, Morton JP, Hawinkels LJAC, Prakash J. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Adv Drug Deliv Rev 2021;174:265-93. [PMID: 33895214 DOI: 10.1016/j.addr.2021.04.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Satchi-Fainaro R, Florindo HF, Vicent MJ. Clinically-relevant and predictive cancer models for nanomedicine evaluation. Adv Drug Deliv Rev 2022;183:114140. [PMID: 35134434 DOI: 10.1016/j.addr.2022.114140] [Reference Citation Analysis]
2 Maneshi P, Mason J, Dongre M, Öhlund D. Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits. Front Cell Dev Biol 2021;9:787485. [PMID: 34901028 DOI: 10.3389/fcell.2021.787485] [Reference Citation Analysis]
3 Li N, Sun Y, Fu Y, Sun K. RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Front Pharmacol 2021;12:734443. [PMID: 35002692 DOI: 10.3389/fphar.2021.734443] [Reference Citation Analysis]
4 Curvello R, Kast V, Abuwarwar MH, Fletcher AL, Garnier G, Loessner D. 3D Collagen-Nanocellulose Matrices Model the Tumour Microenvironment of Pancreatic Cancer. Front Digit Health 2021;3:704584. [PMID: 34713176 DOI: 10.3389/fdgth.2021.704584] [Reference Citation Analysis]
5 Narayanan S, Vicent S, Ponz-sarvisé M. PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem? Front Cell Dev Biol 2021;9:787249. [DOI: 10.3389/fcell.2021.787249] [Reference Citation Analysis]
6 Pednekar KP, Heinrich MA, van Baarlen J, Prakash J. Novel 3D µtissues Mimicking the Fibrotic Stroma in Pancreatic Cancer to Study Cellular Interactions and Stroma-Modulating Therapeutics. Cancers (Basel) 2021;13:5006. [PMID: 34638490 DOI: 10.3390/cancers13195006] [Reference Citation Analysis]
7 Monico DA, Calori IR, Souza C, Espreafico EM, Bi H, Tedesco AC. Melanoma spheroid-containing artificial dermis as an alternative approach to in vivo models. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113207] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao T, Zhang R, He Q, Zhou H, Song X, Gong T, Zhang Z. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming. Acta Biomater 2022;145:122-34. [PMID: 35381402 DOI: 10.1016/j.actbio.2022.03.050] [Reference Citation Analysis]
9 Moura BS, Monteiro MV, Ferreira LP, Lavrador P, Gaspar VM, Mano JF. Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids. Adv Funct Materials. [DOI: 10.1002/adfm.202202825] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Monteiro MV, Rocha M, Gaspar VM, Mano JF. Programmable Living Units for Emulating Pancreatic Tumor-Stroma Interplay. Adv Healthc Mater 2022;:e2102574. [PMID: 35426253 DOI: 10.1002/adhm.202102574] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Monteiro MV, Zhang YS, Gaspar VM, Mano JF. 3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models. Trends Biotechnol 2021:S0167-7799(21)00194-3. [PMID: 34556340 DOI: 10.1016/j.tibtech.2021.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]